+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts

The Retinoblastoma (RB) Tumor Suppressor: Pushing Back against Genome Instability on Multiple Fronts

International Journal of Molecular Sciences 18(8):

The retinoblastoma (RB) tumor suppressor is known as a master regulator of the cell cycle. RB is mutated or functionally inactivated in the majority of human cancers. This transcriptional regulator exerts its function in cell cycle control through its interaction with the E2F family of transcription factors and with chromatin remodelers and modifiers that contribute to the repression of genes important for cell cycle progression. Over the years, studies have shown that RB participates in multiple processes in addition to cell cycle control. Indeed, RB is known to interact with over 200 different proteins and likely exists in multiple complexes. RB, in some cases, acts through its interaction with E2F1, other members of the pocket protein family (p107 and p130), and/or chromatin remodelers and modifiers. RB is a tumor suppressor with important chromatin regulatory functions that affect genomic stability. These functions include the role of RB in DNA repair, telomere maintenance, chromosome condensation and cohesion, and silencing of repetitive regions. In this review we will discuss recent advances in RB biology related to RB, partner proteins, and their non-transcriptional functions fighting back against genomic instability.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 060382123

Download citation: RISBibTeXText

PMID: 28812991

DOI: 10.3390/ijms18081776

Related references

Retinoblastoma tumor suppressor and genome stability. Advances in Cancer Research 85: 13-50, 2002

Role of the retinoblastoma tumor suppressor in the maintenance of genome integrity. Current Molecular Medicine 6(7): 749-757, 2006

Role of the Retinoblastoma Tumor Suppressor in the Maintenance of Genome Integrity. Current Molecular Medicine 6(7): 749-757, 2006

Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability. Cancer Research 63(2): 476-483, 2003

Multiple changes in oncogenes and tumor suppressor genes in human retinoblastoma. Transactions of the American Ophthalmological Society 94: 299-312; Discussion 312-4, 1996

Brg1 coordinates multiple processes during retinogenesis and is a tumor suppressor in retinoblastoma. Development 142(23): 4092-4106, 2015

Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma. Experimental Eye Research 86(2): 201-206, 2008

Linker Histone H1.2 Directs Genome-wide Chromatin Association of the Retinoblastoma Tumor Suppressor Protein and Facilitates Its Function. Cell Reports 19(11): 2193-2201, 2017

The enigmatic oncogene and tumor suppressor-like properties of RAD54B: Insights into genome instability and cancer. Genes Chromosomes and Cancer 56(7): 513-523, 2017

Retinoblastoma tumor suppressor: analyses of dynamic behavior in living cells reveal multiple modes of regulation. Molecular and Cellular Biology 23(22): 8172-8188, 2003

MiR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2. Oncology Reports 32(1): 261-269, 2014

Phosphorylation of the retinoblastoma tumor suppressor protein controls binding of proteins to the c-fos retinoblastoma control element. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY [Author] The 9th International Congress of Immunology : 697, 1995

Trilateral retinoblastoma variant indicative of the relevance of the retinoblastoma tumor-suppressor pathway to medulloblastomas in humans. Journal of Neurosurgery 95(5): 871-878, 2001

A suppressor screen in chlamydomonas identifies novel components of the retinoblastoma tumor suppressor pathway. Genetics 178(3): 1295-1310, 2008

Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Cancer Research 55(24): 6006-6011, 1995